On November 3, 2026 Avenzo Therapeutics, Inc. ("Avenzo"), a clinical-stage biotechnology company developing next-generation oncology therapies, reported that Athena Countouriotis, M.D., Chair, President and CEO, will participate in fireside chats and host investor meetings at the following upcoming investor conferences:

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

3rd Annual Guggenheim Healthcare Innovation Conference
Event:

Fireside Chat

Date:

Tuesday, November 10, 2026

Presentation Time:

1:30 to 1:55 p.m. ET

Stifel 2026 Healthcare Conference
Event:
Fireside Chat

Date:

Wednesday, November 11, 2026

Presentation Time:

11:20 to 11:50 a.m. ET

Live webcasts of the fireside chats will be accessible on the company’s website, www.avenzotx.com, under the Events & Presentations section and an archived recording will be available on the website for 90 days following each presentation.

(Press release, Avenzo Therapeutics, NOV 3, 2026, View Source [SID1234674113])